NCT04412369 (MIIC-MI) is a clinical trial of Non-invasive cardiac imaging in COVID19, sponsored by University of Cambridge.

Who is sponsoring NCT04412369?

NCT04412369 is sponsored by University of Cambridge.

What drugs are being tested in NCT04412369?

Interventions in NCT04412369: Non-invasive cardiac imaging.

What condition does NCT04412369 study?

NCT04412369 studies COVID19, Cardiovascular Diseases.

Is NCT04412369 still recruiting?

NCT04412369 is currently completed. Last updated 19 July 2024.

Last reviewed 2024-07-19 · How we verify

NCT04412369: MIIC-MI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Multi-modality Imaging & Immunophenotyping of COVID-19 Related Myocardial Injury

Completed Last updated 19 July 2024

What this trial tests

trial testing Non-invasive cardiac imaging in COVID19 in 21 participants. Completed in 1 August 2023.

Timeline

1 July 2020

Primary endpoint
1 December 2022

1 August 2023

Quick facts

Lead sponsor	University of Cambridge
Status	Completed
Study type	OBSERVATIONAL
Enrollment	21
Start date	1 July 2020
Primary completion	1 December 2022
Estimated completion	1 August 2023
Sites	1 location across United Kingdom

Drugs / interventions tested

Non-invasive cardiac imaging

Conditions studied

COVID19 — all drugs for COVID19 →
Cardiovascular Diseases — all drugs for Cardiovascular Diseases →

Sponsor

University of Cambridge

Who can join

Adults 18 to 99, any sex, with COVID19 or Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cardiovascular involvement in coronavirus disease-2019 (COVID-19) encompasses a wide range of vascular and myocardial pathologies, including both acute and long-term sequelae. The MIIC-MI study aims to investigate mechanisms of cardiac injury in COVID-19 using multi-modality imaging and immunophenotyping to better understand the link with adverse patient outcomes.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

What we (don't) know about myocardial injury after COVID-19.
Friedrich MG, Cooper LT. · · 2021 · cited 32× · PMID 33713116 · DOI 10.1093/eurheartj/ehab145
Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: protocol design of COVID-HEART-a UK, multicentre, observational study.
Gorecka M, McCann GP, Berry C, Ferreira VM, et al · · 2021 · cited 14× · PMID 34112195 · DOI 10.1186/s12968-021-00752-1
Coronavirus disease 2019-related myocardial injury is associated with immune dysregulation in symptomatic patients with cardiac magnetic resonance imaging abnormalities.
Ćorović A, Zhao X, Huang Y, Newland SR, et al · · 2024 · cited 8× · PMID 39073768 · DOI 10.1093/cvr/cvae159
Novel Radiotracers for Molecular Imaging of Myocardial Inflammation: an Update Focused on Clinical Translation of Non-18F-FDG Radiotracers.
Shi T, Miller EJ. · · 2023 · cited 6× · PMID 36926261 · DOI 10.1007/s12410-023-09574-4

Verify or expand the search:

Other recruiting trials for COVID19

Currently open trials in the same condition.

NCT07337382 — The Optimising Isolation, Quarantine and Distancing Study for COVID-19 · active not recruiting
NCT04376034 — Convalescent Plasma Collection and Treatment in Pediatrics and Adults · Phase 3 · recruiting
NCT04367883 — Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection · recruiting

Other University of Cambridge trials

Trials by the same sponsor.

NCT07106216 — Evaluating Near-infrared Spectroscopy Devices for Monitoring Traumatic Brain Injury · not yet recruiting
NCT07341230 — Deep Brain Stimulation to Understand and Treat Addiction · NA · recruiting
NCT07154836 — Call for Life: Exploring mHealth Solutions for Enhancing Childhood Vaccinations Among Displaced Children in Conflict-aff · NA · enrolling by invitation
NCT06844539 — taRgeting bEtA-Cell Function To achIeVe Remission of Type 2 diAbeTEs · NA · recruiting
NCT07026656 — Pre-clinical Diagnosis Using Integrated Microbial and Host Response Signatures to Improve Outcomes From Ventilator-assoc · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04412369 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Cambridge
Last refreshed: 19 July 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04412369.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing